RxGenomix

RxGenomix is a United States-based company located in Franklin, Tennessee. With a team of nine employees, they generate annual revenue of $2.5 million. RxGenomix specializes in pharmacogenomics (PGx), a field focusing on how an individual's genetic makeup influences their response to medications. They provide healthcare providers with tools and resources to understand and utilize PGx testing. This approach allows providers to analyze specific sections of a patient's DNA to determine the most effective medications and dosages for their unique genetic profile. By integrating PGx testing into their practices, healthcare providers can achieve more personalized treatment plans, minimize the risk of adverse drug events, and ultimately enhance patient outcomes. This personalized approach aims to improve healthcare efficiency and potentially reduce overall costs. For more information on RxGenomix and their pharmacogenomics solutions, please visit their website at rxgenomix.com.